Stem-Cell Clinical Trials Move Debate Beyond Labs
13 October 2011
Professor Pete Coffey (×î×¼µÄÁùºÏ²ÊÂÛ̳ Institute of Ophthalmology), in collaboration with Pfizer, is awaiting regulatory permission to begin an embryonic stem cell trial to treat age-related macular degeneration.